Want to see BIORQ full AI Analyst Report?
Biora Therapeutics (BIORQ) Income Statement
Biora Therapeutics Income Statement
Last quarter (Q3 2024), Biora Therapeutics's total revenue was $32.00K. In Q3, Biora Therapeutics's net income was $-18.40M. See Biora Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| $ 4.00K | $ 305.00K | $ 1.25M | $ 74.31M | $ 143.99M | |
| $ 4.00K | $ 305.00K | $ 1.25M | $ -19.12M | $ 43.49M | |
| $ 67.15M | $ 62.09M | $ 119.08M | $ 176.07M | $ 183.61M | |
| Depreciation and Amortization | $ 555.00K | $ 907.00K | $ 1.44M | $ 1.44M | $ 4.68M |
| $ -114.05M | $ -37.35M | $ -164.57M | $ -106.18M | $ -135.44M | |
| $ -67.14M | $ -61.78M | $ -117.84M | $ -107.62M | $ -140.12M | |
| $ -57.28M | $ 12.53M | $ -60.80M | $ -35.00M | $ -8.62M | |
| $ -124.42M | $ -49.25M | $ -178.64M | $ -142.62M | $ -148.74M | |
| $ -124.11M | $ -38.16M | $ -178.52M | $ -192.53M | $ -148.04M | |
| Per Share Metrics | |||||
| Basic EPS | $ -78.70 | $ -6.40 | $ -46.42 | $ -86.30 | $ -80.17 |
| Diluted EPS | $ -78.70 | $ -6.40 | $ -46.42 | $ -86.30 | $ -80.17 |
| Weighted Average Shares Outstanding | 1.58M | 763.51K | 384.62K | 223.09K | 184.66K |
| Weighted Average Shares Outstanding (Diluted) | 1.58M | 763.51K | 384.62K | 223.09K | 184.66K |
Currency in USD
